“IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE”. Frontier in Medical and Health Research, vol. 4, no. 3, Mar. 2026, pp. 4646-54, https://fmhr.net/index.php/fmhr/article/view/3859.